Objective
The Metabolic Syndrome is a major risk marker for type 2 diabetes and for cardiovascular disease. Recent evidence suggests a crucial role for fat accumulation in the liver in the development of the Metabolic Syndrome. The hypothesis of the HEPADIP project is that this reflects an alteration in metabolic relationships or the signalling between adipose tissue and liver. The project objectives are therefore to address the role of adipose tissue and the liver, and the interaction between them, in the development of the disturbances of lipid metabolism, insulin signalling, and glucose homeostasis in the Metabolic Syndrome in order to identify, validate and develop novel targets for diagnosis, characterization, prevention and treatment of the syndrome. The Consortium comprises of 26 participants, 6 of which are SMEs, from 11 European countries. The project is organised in seven lines of research for the study of the biology of adipose tissue and the liver, the integrated function of the adipose tissue - liver axis in rodent models and in humans, and clinical and genetic epidemiology of the syndrome. Studies will be integrated across all levels from the molecular/genetic level, to the whole organism, and to the human population. The strategy emplies interactions between a hypothesis-driven and an explorative "omics" approach. Considerable amounts of data from genomics, transcriptomics, proteomics and metabolomics will be generated, and they will be integrated and analyzed with the novel "omics" and bioinformatics technologies. At a later stage, further integration will take place with validation and development of novel targets, and SMEs will play a key role in this phase. The Metabolic Syndrome may differ in its characteristics between men and women, and study design and analysis will address this wherever relevant. The HEPADIPproject will have the best possible prior likelihood of providing tools to combat the Metabolic Syndrome.
Fields of science
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomics
- medical and health scienceshealth sciencespublic healthepidemiology
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- medical and health sciencesbasic medicinephysiologyhomeostasis
Call for proposal
FP6-2004-LIFESCIHEALTH-5
See other projects for this call
Funding Scheme
IP - Integrated ProjectCoordinator
HILLERØD
Denmark
See on map
Participants (23)
N/A STOCKHOLM
See on map
PARIS
See on map
MUENCHEN
See on map
100 GÖTEBORG
See on map
PRAHA 10
See on map
DERIO, BIZKAIA
See on map
BRUSSELS
See on map
CAMBRIDGE
See on map
LAUSANNE
See on map
245 LILLE
See on map
PO Box 30001 GRONINGEN
See on map
1000 ESPOO
See on map
OXFORD
See on map
100 HELSINKI
See on map
TURKU
See on map
ANTWERPEN
See on map
BAGSVÆRD
See on map
HANNOVER
See on map
LOOS
See on map
DERIO
See on map
DERIO
See on map
ROEDOVRE
See on map
365 AALBORG
See on map